
About Bluefish Pharmaceuticals
Bluefish Pharmaceuticals is a Healthcare company based in Stockholm (Sweden) founded in 2005. Bioequivalent generic pharmaceuticals are developed and manufactured affordably. Bluefish Pharmaceuticals has raised $21.67 million across 5 funding rounds from investors including Catella, NXT2B and Varenne. The company has 81 employees. Its Indian entity Bluefish Pharmaceuticals Private Limited reported revenue of βΉ24.17 Cr. Bluefish Pharmaceuticals offers products and services including Generic Medicines and Partnering Services. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Manufacturer of affordable generic pharmaceutical products. It focuses on developing and marketing bioequivalent versions of off-patent medications. The company partners with manufacturing experts to ensure rigorous quality standards are met throughout the product lifecycle, from development to distribution. Its marketing strategy emphasizes organic growth and market-specific approaches, targeting various healthcare institutions. The products are derived from well-established generic substances, with extensive research supporting their efficacy and safety. This approach minimizes development time and optimizes investments, resulting in a cost-effective product portfolio.
- Headquarters Stockholm, Sweden
- Employees 81
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website bluefishpharma.com
- Social LinkedIn Facebook
- Legal Name Bluefish Pharmaceuticals Private Limited
- Date of Incorporation 28 Sep, 2006
- Jurisdiction Whitefield Ashram Road Bangalore, Karnataka, India
- Indian entity revenue₹24.17 Cr
FY 2025 · -2% YoY
- Indian entity net profit₹1.76 Cr
FY 2025 · 7% margin
- Indian entity EBITDA₹2.85 Cr
FY 2025 · 12% margin
- Total Equity Funding$21.67M (USD)
in 5 rounds
- Latest Funding Round$3.3M (USD), Series B
May 2014
- InvestorsCatella
& 2 more
- Employee Count81
Associated legal entities of Bluefish Pharmaceuticals
Bluefish Pharmaceuticals operates through Bluefish Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bluefish Pharmaceuticals Private Limited CIN U02423KA2006PTC049950 | Active | 28 Sep 2006 | Bangalore, Karnataka | ₹24.2 Cr | 81 | 2 | View details |
Products & Services of Bluefish Pharmaceuticals
Bluefish Pharmaceuticals offers a comprehensive portfolio of products and services, including Generic Medicines and Partnering Services.
Generic medicines are manufactured for various therapeutic areas, with bioequivalence established to originator products to ensure affordability and efficacy.
Partnerships are provided with development and manufacturing experts to optimize product portfolios and supply chains in the pharmaceutical sector.
Funding Insights of Bluefish Pharmaceuticals
Bluefish Pharmaceuticals has successfully raised a total of $21.67M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $3.3 million completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $21.67M
- Total Rounds 5
- Last Round Series B β $3.3M
- Investors Count 3
All 5 funding rounds of Bluefish Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Bluefish Pharmaceuticals
Bluefish Pharmaceuticals has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Catella, NXT2B and Varenne.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
NXT2B is recognized as a venture capital investment firm. | 2011 | nxt2b.com | Uppsala, Sweden | |
Companies are supported by Varenne in their growth journey. | varenne.se | Stockholm, Sweden | ||
M&A strategic advisory and real estate services are provided globally. | 1987 | catella.com | Stockholm, Sweden |
Investor details for Bluefish Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Bluefish Pharmaceuticals Private Limited (Bluefish Pharmaceuticals)
Bluefish Pharmaceuticals Private Limited is the primary company behind Bluefish Pharmaceuticals. The board of Bluefish Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Vivekanandan Sundaramurthy, appointed in 2021. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vivekanandan Sundaramurthy DIN 09289475 | Director | 23 Aug 2021 | 5 yrs 2 mo | Bluefish Pharmaceuticals Private Limited |
| Astha Sehgal DIN 09404915 | Director | 19 Nov 2021 | 5 yrs | Bluefish Pharmaceuticals Private Limited |
People of Bluefish Pharmaceuticals
14 people are tracked at Bluefish Pharmaceuticals (7 in leadership, 7 in team); the tracked headcount is 81.
| Name | Role | Group |
|---|---|---|
Fredrik Sehlstedt | Chief Financial Officer | Leadership |
| Head – Human Resources | Leadership | |
Ingrid Smerdova | Director Business Development | Leadership |
Vivekanand Sundaramurthy | Head – Research & Development | Leadership |
Paul Lister | Head Of Supply Chain | Leadership |
Yogesh Kota | Director Operation And Head Of Supplier Relations- SCM | Leadership |
Sunil Bolar | Director Of Business Development | Leadership |
Eden Kebede | Manager-business Development | Team |
Savinay Gokavi | Manager- TT & Launch Manager | Team |
Louise Danielsson | Sales Manager | Team |
Wojciech Stras | Country Manager | Team |
Belén Hernández López | Finance, Operations & Customer Service | Team |
Ana Aguado González | Sales Lead | Team |
Kenneth Edman | Interim Senior Accountant | Team |
Complete people profiles for Bluefish Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Bluefish Pharmaceuticals
Figures of Bluefish Pharmaceuticals Private Limited, the primary company behind Bluefish Pharmaceuticals, for FY 2025. Revenue was ₹24.17 Cr (-2% year on year). Net profit was ₹1.76 Cr (7% margin). EBITDA was ₹2.85 Cr (12% margin). Revenue has grown at a compounded annual rate of +5% over three years and +4% over five years.
- ₹24.17 CrRevenue · FY 2025 · -2% YoY
- ₹1.76 CrNet profit · 7% margin
- ₹2.85 CrEBITDA · 12% margin
- ₹2.40 CrPaid-up capital
- 81Employees (provident fund records)
- +5%Revenue CAGR, 3 years
- +4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bluefish Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Bluefish Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Bluefish Pharmaceuticals
3 dated milestones of Bluefish Pharmaceuticals across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Bluefish Pharmaceuticals is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $3.3M.
Web traffic of Bluefish Pharmaceuticals
The website of Bluefish Pharmaceuticals (bluefishpharma.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 0.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bluefish Pharmaceuticals
Bluefish Pharmaceuticals was founded in 2005 and raised its 1st funding round 1 year after it was founded.
Bluefish Pharmaceuticals is headquartered in Stockholm, Sweden.
Bluefish Pharmaceuticals is a funded company, having raised a total of $21.67M across 5 funding rounds to date.
Bluefish Pharmaceuticals has 81 employees.
The primary company behind Bluefish Pharmaceuticals, Bluefish Pharmaceuticals Private Limited, reported revenue of βΉ24.17 Cr for FY 2025, down 2% year on year.
Manufacturer of affordable generic pharmaceutical products. It focuses on developing and marketing bioequivalent versions of off-patent medications. The company partners with manufacturing experts to ensure rigorous quality standards are met throughout the product lifecycle, from development to distribution. Its marketing strategy emphasizes organic growth and market-specific approaches, targeting various healthcare institutions. The products are derived from well-established generic substances, with extensive research supporting their efficacy and safety. This approach minimizes development time and optimizes investments, resulting in a cost-effective product portfolio.
Bluefish Pharmaceuticals offers Generic Medicines and Partnering Services.
Bluefish Pharmaceuticals operates through Bluefish Pharmaceuticals Private Limited.
The legal entities of Bluefish Pharmaceuticals currently have 2 directors, including Vivekanandan Sundaramurthy, Astha Sehgal.